Publication:

Disinhibition, an emerging pharmacology of learning and memory

Loading...
Thumbnail Image

Open/View Files

Date

2017

Journal Title

Journal ISSN

Volume Title

Publisher

F1000Research
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Möhler, Hanns, and Uwe Rudolph. 2017. “Disinhibition, an emerging pharmacology of learning and memory.” F1000Research 6 (1): F1000 Faculty Rev-101. doi:10.12688/f1000research.9947.1. http://dx.doi.org/10.12688/f1000research.9947.1.

Abstract

Learning and memory are dependent on interactive excitatory and inhibitory mechanisms. In this review, we discuss a mechanism called disinhibition, which is the release of an inhibitory constraint that effectively results in an increased activity in the target neurons (for example, principal or projection neurons). We focus on discussing the role of disinhibition in learning and memory at a basic level and in disease models with cognitive deficits and highlight a strategy to reverse cognitive deficits caused by excess inhibition, through disinhibition of α5-containing GABA A receptors mediating tonic inhibition in the hippocampus, based on subtype-selective negative allosteric modulators as a novel class of drugs.

Description

Research Data

Keywords

Articles, Cognitive Neuroscience, Medical Genetics, Molecular Pharmacology, Neurobiology of Disease & Regeneration, Neuronal Signaling Mechanisms, Neuropharmacology & Psychopharmacology, Pavlovian learning, disinhibition, somatostatin, GABAA, allosteric modulators

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories